Ascendis Pharma Aktie
WKN DE: A14M6X / ISIN: US04351P1012
19.09.2024 03:33:23
|
Ascendis Pharma Commences Underwritten Public Offering Of $300 Mln Of ADSs
(RTTNews) - Ascendis Pharma A/S (ASND) said that it has commenced an underwritten public offering of $300 million of American Depositary Shares or "ADSs", each of which represents one ordinary share of Ascendis.
In addition, the company said it expects to grant the underwriters a 30-day option to purchase up to an additional $45 million of ADSs at the public offering price, less the underwriting commissions.
The offering is subject to market and other conditions.
J.P. Morgan, Morgan Stanley, Evercore ISI and Goldman Sachs & Co. LLC are acting as joint book-running managers for the proposed offering.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ascendis Pharma (spons. ADRs)mehr Nachrichten
11.02.25 |
Ausblick: Ascendis Pharma (spons ADRs) legt Quartalsergebnis vor (finanzen.net) |
Analysen zu Ascendis Pharma (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Ascendis Pharma (spons. ADRs) | 126,00 | 3,28% |
|